Over the past 12 months, 9 insiders at Vir Biotechnology, Inc. filed 50 open-market SEC Form 4 transactions on VIR: 0 purchases worth $0 and 50 sales worth $20.8M. Insiders have been net sellers over this period. The most recent filing was on Apr 6, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 6, 26 | Backer Marianne DePresident and CEO | SELL | 72.6K | $9.16 | $664K |
| Mar 23, 26 | Brent SabatiniSVP, Chief Accounting Officer | SELL | 7.7K | $9.12 | $70K |
| Mar 2, 26 | Vicki L SatoDirector | SELL | 21.8K | $9.98 | $207K |
| Feb 25, 26 | Mark EisnerEVP and Chief Medical Officer | SELL | 1.9K | $9.82 | $19K |
| Feb 25, 26 | Verneuil Vanina DeEVP, General Counsel, Corp Sec | SELL | 13.7K | $9.82 | $135K |
| Feb 24, 26 | Backer Marianne DeChief Executive Officer | SELL | 14.8K | $9.53 | $141K |
| Feb 24, 26 | Mark EisnerEVP and Chief Medical Officer | SELL | 1.6K | $9.53 | $15K |
| Feb 24, 26 | Jason O'ByrneEVP & Chief Financial Officer | SELL | 1.6K | $9.53 | $16K |
| Feb 24, 26 | Vicki L SatoDirector | SELL | 42.2K | $10.26 | $411K |
| Feb 24, 26 | Brent SabatiniSVP, Chief Accounting Officer | SELL | 1.4K | $9.53 | $14K |
| Feb 24, 26 | Verneuil Vanina DeEVP, General Counsel, Corp Sec | SELL | 3.1K | $9.53 | $30K |
| Feb 23, 26 | Backer Marianne DeChief Executive Officer | SELL | 19.0K | $7.45 | $142K |
| Feb 23, 26 | Mark EisnerEVP and Chief Medical Officer | SELL | 2.1K | $7.45 | $16K |
| Feb 23, 26 | Jason O'ByrneEVP & Chief Financial Officer | SELL | 2.1K | $7.45 | $16K |
| Feb 23, 26 | Brent SabatiniSVP, Chief Accounting Officer | SELL | 1.8K | $7.45 | $14K |
| Feb 23, 26 | Verneuil Vanina DeEVP, General Counsel, Corp Sec | SELL | 4.4K | $7.45 | $33K |
| Feb 13, 26 | Brent SabatiniSVP, Chief Accounting Officer | SELL | 1.5K | $7.79 | $12K |
| Feb 2, 26 | Vicki L SatoDirector | SELL | 22.0K | $7.71 | $170K |
| Jan 2, 26 | Vicki L SatoDirector | SELL | 22.0K | $5.93 | $130K |
| Dec 1, 25 | Vicki L SatoDirector | SELL | 22.0K | $6.00 | $132K |
| Dec 1, 25 | Svf Endurance (cayman) LtdTenPercentOwner | SELL | 191.9K | $5.98 | $1.1M |
| Nov 28, 25 | Softbank Vision Fund (aiv M1) L.p.TenPercentOwner | SELL | 61.5K | $6.44 | $396K |
| Nov 26, 25 | Softbank Vision Fund (aiv M1) L.p.TenPercentOwner | SELL | 127.9K | $6.39 | $818K |
| Nov 25, 25 | Svf Endurance (cayman) LtdTenPercentOwner | SELL | 236.0K | $6.38 | $1.5M |
| Nov 24, 25 | Svf Endurance (cayman) LtdTenPercentOwner | SELL | 227.8K | $6.15 | $1.4M |
| Nov 17, 25 | Jason O'ByrneEVP & Chief Financial Officer | SELL | 6.8K | $5.56 | $38K |
| Nov 5, 25 | Verneuil Vanina DeEVP, General Counsel, Corp Sec | SELL | 2.4K | $5.16 | $12K |
| Nov 3, 25 | Vicki L SatoDirector | SELL | 22.0K | $5.64 | $124K |
| Nov 3, 25 | Verneuil Vanina DeEVP and General Counsel | SELL | 1.4K | $5.86 | $8K |
| Oct 29, 25 | Svf Endurance (cayman) LtdTenPercentOwner | SELL | 100 | $6.49 | $649 |
| Oct 28, 25 | Svf Endurance (cayman) LtdTenPercentOwner | SELL | 24.5K | $6.50 | $159K |
| Oct 27, 25 | Sb Investment Advisers (uk) LtdTenPercentOwner | SELL | 66.4K | $6.05 | $402K |
| Oct 24, 25 | Sb Investment Advisers (uk) LtdTenPercentOwner | SELL | 46.7K | $5.96 | $278K |
| Oct 23, 25 | Sb Investment Advisers (uk) LtdTenPercentOwner | SELL | 154.4K | $5.99 | $925K |
| Oct 22, 25 | Sb Investment Advisers (uk) LtdTenPercentOwner | SELL | 144.3K | $6.15 | $887K |
| Oct 21, 25 | Svf Endurance (cayman) LtdTenPercentOwner | SELL | 109.7K | $6.30 | $691K |
| Oct 20, 25 | Svf Endurance (cayman) LtdTenPercentOwner | SELL | 220.5K | $6.20 | $1.4M |
| Oct 16, 25 | Svf Endurance (cayman) LtdTenPercentOwner | SELL | 12.8K | $6.10 | $78K |
| Oct 15, 25 | Svf Endurance (cayman) LtdTenPercentOwner | SELL | 16.7K | $6.07 | $101K |
| Oct 10, 25 | Softbank Vision Fund (aiv M1) L.p.TenPercentOwner | SELL | 2.3K | $6.08 | $14K |
| Oct 9, 25 | Softbank Vision Fund (aiv M1) L.p.TenPercentOwner | SELL | 249.1K | $6.14 | $1.5M |
| Oct 8, 25 | Sb Investment Advisers (uk) LtdTenPercentOwner | SELL | 466.2K | $6.05 | $2.8M |
| Oct 7, 25 | Sb Investment Advisers (uk) LtdTenPercentOwner | SELL | 72.1K | $5.60 | $404K |
| Oct 6, 25 | Svf Endurance (cayman) LtdTenPercentOwner | SELL | 74.0K | $5.69 | $421K |
| Oct 3, 25 | Svf Endurance (cayman) LtdTenPercentOwner | SELL | 450.3K | $5.56 | $2.5M |
| Oct 1, 25 | Vicki L SatoDirector | SELL | 22.0K | $5.84 | $128K |
| Sep 2, 25 | Vicki L SatoDirector | SELL | 22.0K | $4.99 | $110K |
| Aug 1, 25 | Vicki L SatoDirector | SELL | 22.0K | $4.99 | $110K |
| Jul 17, 25 | Mark EisnerEVP and Chief Medical Officer | SELL | 3.6K | $5.47 | $20K |
| Jul 15, 25 | Mark EisnerEVP and Chief Medical Officer | SELL | 6.8K | $5.47 | $37K |
Over the past 12 months, insiders at Vir Biotechnology, Inc. filed 0 open-market purchases worth $0 and 50 sales worth $20.8M on VIR, which makes them net sellers over the period. The most recent Form 4 was filed on Apr 6, 26.
9 different insiders at Vir Biotechnology, Inc. filed open-market SEC Form 4 transactions on VIR over the last 12 months.
InsiderTape plots every VIR insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Vir Biotechnology, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →